AstraZeneca non-exec takes more shares
A round-up of the biggest director buys today so far.
Jean-Phillippe Courtois, a non-executive director at AstraZeneca, has spent nearly £50,000 upping his stake in the drug giant.
He bought 2,135 shares for 2,299p each and now has 2,635.
News of his purchase came on the same day AstraZeneca was celebrating a favourable decision from US regulators regarding its new drug application for diabetes treatment ONGLYZA.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee decided that the data supporting the drug application for ONGLYZA were sufficient to discount unacceptable cardiovascular risk.
Courtois, who is also the President of software company Microsoft's non-US operations, was appointed to Astra's board on February 18.
Top Director Buys
Value: £99,120
Value: £99,120
Value: £98,000
Value: £49,084
Value: £25,002
Value: £25,000
Value: £25,000
Value: £14,600
Value: £13,411
Value: £12,250
Top Director Sells
Value: £2,800,000
Value: £321,247
Value: £10,040
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
‘Inheritance tax insurance’ enquiries are soaring – but is it worth it?
Premiums for whole of life insurance can run to £5,000 a month to cover a £300,000 inheritance tax bill, with policies costing more the older you take them out.
-
MPs warn over Lifetime ISAs which could leave savers out of pocket
The Treasury Committee has highlighted confusion around the Lifetime ISA withdrawal charge, which risks consumers losing “a significant part of their savings”